NIAID plays a leading role in the discovery, development, and characterization of new vaccine adjuvants that may be used to: improve the efficacy of current vaccines; design new or improved vaccines for existing and emerging infectious diseases; and develop vaccines to treat allergies, autoimmune diseases, and cancer.
Areas of Adjuvant Research
Additional Resources
Contact Information
Email - DAITAdjuvantGrp@mail.nih.gov
Points of contact for each program can be found on individual program pages.
Content last reviewed on